Elpat Injection (L-Carnitine)

Adult administration

1. Primary and secondary carnitine deficiency Myocardial metabolic dysfunction due to ischemic heart disease: angina, acute myocardial infarction Adults: Administer 2~3 grams per day of L-carnitine in 2~3 divided doses by intramuscular or intravenous injection. Adjust the dose as appropriate according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10~20 milligrams/kilogram intravenously over 2~3 minutes at the end of each hemodialysis session. The dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

This injection must be handled very carefully as glass fragments may mix when opening the vial. Special caution should be exercised especially for children and the elderly. It should not be used in patients with allergic reactions to this medication. Nausea or vomiting may occur temporarily during use. Rarer side effects such as changes in body odor or gastritis could occur, and patients with a history of seizures may experience seizures more frequently or severely. Various side effects have been reported in chronic hemodialysis patients, including abdominal pain, allergic reactions, headaches, and infections. The drug may affect the cardiovascular system, leading to arrhythmias or fluctuations in blood pressure. Gastrointestinal symptoms such as loss of appetite, constipation, diarrhea, nausea, and vomiting may also occur. Muscle symptoms, including myalgia or leg cramps, have been reported. Neurological symptoms may include dizziness, anxiety, depression, and insomnia. Respiratory symptoms such as increased bronchitis or coughing may occur. Skin reactions such as rashes or itching have been reported, and angioedema has been reported in rare cases. Safety during pregnancy has not been established; it should only be used in women of childbearing potential when the benefits outweigh the risks. Caution is also needed during breastfeeding due to the potential transfer of the drug into breast milk.

• Temporary area
• vomiting
• body odor
• gastritis
• seizures
• abdominal pain
• accidental injury
• allergic reaction
• asthma
• low back pain

This medication is sensitive to light and should be stored in a container that blocks light. It is also important to store it at room temperature between 1 to 30 degrees Celsius to maintain the drug's effectiveness.

Appearance

Brown ampoule containing a colorless to light yellow clear liquid

Package unit

50 ampoules/box [(5 ml/ampoule)]